Global management consulting, technology services and outsourcing company Accenture has completed its acquisition of US company Octagon Research Solutions, Inc, for an undisclosed sum.
Accenture’s acquisition of the provider of clinical and regulatory information management solutions and software for the pharmaceutical industry had been announced on 2 August.
Under the deal, Accenture is looking to enhance its clinical services capabilities, including data management, clinical programming and safety case processing.
Accenture is also seeking to add regulatory submission services, thereby extending its business process outsourcing capabilities for the pharmaceutical industry. As a result, it will be able to provide comprehensive clinical and regulatory services to pharmaceutical companies globally, helping them get medicines to market more quickly and cost effectively.
“Our pharmaceutical clients around the world are looking for proven clinical and regulatory services that can improve the efficiency and effectiveness of their drug development business,” said David Boath, North American managing director for Accenture’s Life Sciences industry group.
“With Octagon’s deep regulatory expertise and proprietary software – coupled with Accenture’s global delivery network and R&D experience across the pharmaceutical industry – we can now offer a software-enabled clinical and regulatory services solution from the initial clinical protocol design through to regulatory submission.”
